NO158100C - Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater.

Info

Publication number
NO158100C
NO158100C NO823732A NO823732A NO158100C NO 158100 C NO158100 C NO 158100C NO 823732 A NO823732 A NO 823732A NO 823732 A NO823732 A NO 823732A NO 158100 C NO158100 C NO 158100C
Authority
NO
Norway
Prior art keywords
pyridine
ingredients
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO823732A
Other languages
English (en)
Norwegian (no)
Other versions
NO823732L (no
NO158100B (no
Inventor
William Richard King
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO823732L publication Critical patent/NO823732L/no
Publication of NO158100B publication Critical patent/NO158100B/no
Publication of NO158100C publication Critical patent/NO158100C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO823732A 1981-11-10 1982-11-09 Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater. NO158100C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8133942 1981-11-10
GB8133930 1981-11-10
GB8213846 1982-05-12

Publications (3)

Publication Number Publication Date
NO823732L NO823732L (no) 1983-05-11
NO158100B NO158100B (no) 1988-04-05
NO158100C true NO158100C (no) 1988-07-13

Family

ID=27261362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823732A NO158100C (no) 1981-11-10 1982-11-09 Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater.

Country Status (17)

Country Link
US (1) US4603139A (de)
EP (1) EP0079083B1 (de)
KR (1) KR890000022B1 (de)
AR (1) AR241247A1 (de)
AU (1) AU9030682A (de)
DD (1) DD205904A5 (de)
DK (1) DK161325C (de)
ES (2) ES517193A0 (de)
FI (1) FI79312C (de)
GB (1) GB2113675B (de)
GR (1) GR76746B (de)
IE (1) IE56478B1 (de)
IL (1) IL67206A0 (de)
MC (1) MC1491A1 (de)
NO (1) NO158100C (de)
PH (1) PH22764A (de)
PT (1) PT75820B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273461D1 (en) * 1981-08-19 1986-10-30 Merck Patent Gmbh 2-arylimidazopyridines
RO86850B (ro) * 1982-05-03 1985-05-31 Eli Lilly And Company Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine
US4904785A (en) * 1982-05-03 1990-02-27 Eli Lilly And Company 2-phenylimidazo[4,5-c]pyridines
US4758574A (en) * 1982-05-03 1988-07-19 Eli Lilly And Company 2-phenylimidazio (4,5-c) pyridines
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4515796A (en) * 1983-09-08 1985-05-07 Eli Lilly And Company Certain naphthalenyl imidazo compounds and their pharmaceutical use
US4533734A (en) * 1983-11-10 1985-08-06 Eli Lilly And Company Inotropic agents
DE3346602A1 (de) * 1983-12-23 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazo(4,5-c)pyridin-one, deren herstellung und diese verbindungen enthaltende arzneimittel
DE3347290A1 (de) * 1983-12-28 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
GR850426B (de) * 1984-02-24 1985-06-18 Lilly Co Eli
US4578387A (en) * 1984-03-05 1986-03-25 Eli Lilly And Company Inotropic agents
DE3445299A1 (de) * 1984-12-12 1986-06-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1295330C (en) * 1985-03-29 1992-02-04 James M. Greene Synthesis of inotropic imidazo(4,5-c) pyridine
DE3522230A1 (de) * 1985-06-21 1987-01-02 Thomae Gmbh Dr K Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4740599A (en) * 1986-10-03 1988-04-26 Eli Lilly And Company Synthesis of alkylsulfinyl substituted 2-phenylimidazo(4,5-c)pyridines
EP0322149A2 (de) * 1987-12-22 1989-06-28 Eli Lilly And Company Hydrat eines inotropischen Mittels
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents
ES2061247T3 (es) * 1990-05-09 1994-12-01 Pfizer Imidazo (4,5-c) piridinas con actividad antagonista del paf.
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ATE228131T1 (de) * 1996-05-15 2002-12-15 Altana Pharma Ag Imidazopyridine
DK0937075T3 (da) * 1996-11-11 2004-04-13 Altana Pharma Ag Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer
AU2001259707A1 (en) * 2000-06-14 2001-12-24 Warner Lambert Company 6,5-fused bicyclic heterocycles
ES2273225T3 (es) * 2003-02-25 2007-05-01 Altana Pharma Ag Derivados de imidazo (4,5-b) quinolina y su uso como inhibidores de la no-sintasa.
KR20060087386A (ko) * 2005-01-28 2006-08-02 주식회사 대웅제약 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
WO2007034277A1 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
KR101686685B1 (ko) 2008-10-31 2016-12-14 제넨테크, 인크. 피라졸로피리미딘 ｊａｋ 억제제 화합물 및 방법
UA110324C2 (en) 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
CN102595900B (zh) * 2009-08-10 2015-07-15 萨穆梅德有限公司 Wnt信号传导途径的吲唑抑制剂及其治疗用途
ES2550820T3 (es) 2009-12-21 2015-11-12 Samumed, Llc 1H-pirazol[3,4-beta]piridinas y usos terapéuticos de las mismas
MX2012010265A (es) * 2010-03-17 2012-10-01 Hoffmann La Roche Compuestos de imidazopiridina, composiciones y metodos de uso.
WO2012035039A1 (en) 2010-09-15 2012-03-22 F. Hoffmann-La Roche Ag Azabenzothiazole compounds, compositions and methods of use
CN103313987A (zh) 2010-11-19 2013-09-18 弗·哈夫曼-拉罗切有限公司 吡唑并吡啶化合物、吡唑并吡啶化合物以及它们作为tyk2抑制剂的用途
EP2755483B1 (de) 2011-09-14 2018-11-28 Samumed, LLC Indazol-3-carboxamide und ihre verwendung als wnt/b-catenin-signalisierungsweghemmer
PH12017500997A1 (en) 2012-04-04 2018-02-19 Samumed Llc Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
ME03573B (de) 2012-05-04 2020-07-20 Samumed Llc 1h-pyrazolo[3,4-beta]pyridine und therapeutische verwendung davon
WO2014110086A2 (en) 2013-01-08 2014-07-17 Samumed, Llc 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
EP2818472A1 (de) * 2013-06-27 2014-12-31 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Imidazo[4,5-c]pyridin- und Pyrrolo[3,2-c]pyridinverbindungen als Modulatoren der G-Protein-Gekoppelte Rezeptoren Kinase 5 (GRK5)
HUE049733T2 (hu) * 2013-07-02 2020-10-28 Syngenta Participations Ag Növényvédõszerként aktív biciklusos vagy triciklusos heterociklusok kéntartalmú szubsztituensekkel
CN107652292B (zh) * 2013-07-02 2020-11-17 先正达参股股份有限公司 有杀有害生物活性的具有含硫取代基的二环或三环杂环
US11229208B2 (en) 2013-07-02 2022-01-25 Syngenta Participations Ag Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
WO2015121136A1 (de) 2014-02-17 2015-08-20 Bayer Cropscience Ag 2-(het)aryl-substituierte kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CN109970743B (zh) 2014-05-23 2022-03-04 豪夫迈·罗氏有限公司 为jak抑制剂的5-氯-2-二氟甲氧基苯基吡唑并嘧啶化合物
JP6695326B2 (ja) 2014-08-21 2020-05-20 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する殺有害生物的に活性な複素環式誘導体
WO2016040181A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040185A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
WO2016040184A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040182A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
WO2016040190A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040180A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040193A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040188A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016058928A1 (en) * 2014-10-14 2016-04-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
SI3233851T1 (sl) * 2014-12-17 2020-10-30 Syngenta Participations Ag Pesticidno aktivni heterociklični derivati s substituenti, ki vsebujejo žveplo
EP3240786B1 (de) * 2014-12-31 2019-03-27 Syngenta Participations AG Pestizidwirksame polycyclische derivate mit schwefelhaltigen substituenten
UY36547A (es) * 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
WO2017024021A1 (en) 2015-08-03 2017-02-09 Samumed, Llc 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
WO2017023972A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
US10206909B2 (en) 2015-08-03 2019-02-19 Samumed, Llc 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
WO2017023980A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
US10285983B2 (en) 2015-08-03 2019-05-14 Samumed, Llc 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
WO2017024015A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017023975A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
WO2017023987A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
WO2017023993A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017023989A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
US10463651B2 (en) 2015-08-03 2019-11-05 Samumed, Llc 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
US10519169B2 (en) 2015-08-03 2019-12-31 Samumed, Llc 3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
WO2017024026A1 (en) 2015-08-03 2017-02-09 Samumed, Llc 3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
US10231956B2 (en) 2015-08-03 2019-03-19 Samumed, Llc 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10604512B2 (en) 2015-08-03 2020-03-31 Samumed, Llc 3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
WO2017023988A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
US10206908B2 (en) 2015-08-03 2019-02-19 Samumed, Llc 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
WO2017079759A1 (en) 2015-11-06 2017-05-11 Samumed, Llc 2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
MX2018014871A (es) 2016-06-01 2019-11-05 Samumed Llc Proceso de preparacion de n-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4, 5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida .
EP3528808B1 (de) 2016-10-21 2021-10-06 BioSplice Therapeutics, Inc. Verfahren zur verwendung von indazol-3-carboxamiden und deren verwendung als hemmer des wnt/b-catenin-signalwegs
JP2019533702A (ja) 2016-11-07 2019-11-21 サミュメッド リミテッド ライアビリティ カンパニー 単回用量の調整済み注射用製剤
TW201902896A (zh) 2017-05-22 2019-01-16 瑞士商赫孚孟拉羅股份公司 治療化合物及組合物及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA820316A (en) * 1969-08-12 Fisons Pest Control Limited Substituted heterocyclic compounds
US3985891A (en) * 1973-02-03 1976-10-12 Boehringer Ingelheim Gmbh 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
FI58126C (fi) * 1973-02-03 1980-12-10 Thomae Gmbh Dr K Foerfarande foer framstaellning av kardiotona och blodtryckssaenkande 2-fenyl-1h-imidatso(4,5-b)pyridiner
US3891660A (en) * 1974-02-07 1975-06-24 Squibb & Sons Inc Derivatives of 1H-imidazo{8 4,5-c{9 pyridine-7-carboxylic acids and esters
SU566842A1 (ru) * 1976-01-06 1977-07-30 Донецкое Отделение Физико-Органической Химии Института Физической Химии Им.Л.В.Писаржевского Ан Украинской Сср Способ получени замещенных имидазопиридинов
US4281005A (en) * 1979-03-05 1981-07-28 Merck & Co., Inc. Novel 2-pyridylimidazole compounds
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
DE3037464A1 (de) * 1980-10-03 1982-05-19 Dr. Karl Thomae Gmbh, 7950 Biberach 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel
DE3273461D1 (en) * 1981-08-19 1986-10-30 Merck Patent Gmbh 2-arylimidazopyridines
RO86850B (ro) * 1982-05-03 1985-05-31 Eli Lilly And Company Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO823732L (no) 1983-05-11
IL67206A0 (en) 1983-03-31
FI79312B (fi) 1989-08-31
GB2113675B (en) 1985-10-30
DK161325B (da) 1991-06-24
IE822667L (en) 1983-05-10
ES8503351A1 (es) 1985-02-16
FI823846L (fi) 1983-05-11
IE56478B1 (en) 1991-08-14
DD205904A5 (de) 1984-01-11
ES8401486A1 (es) 1983-12-01
KR840002398A (ko) 1984-07-02
US4603139A (en) 1986-07-29
EP0079083B1 (de) 1991-02-27
PT75820B (en) 1986-06-11
AR241247A1 (es) 1992-03-31
FI823846A0 (fi) 1982-11-09
GR76746B (de) 1984-08-30
NO158100B (no) 1988-04-05
GB2113675A (en) 1983-08-10
EP0079083A1 (de) 1983-05-18
ES517193A0 (es) 1983-12-01
FI79312C (fi) 1989-12-11
PT75820A (en) 1982-12-01
KR890000022B1 (ko) 1989-03-06
MC1491A1 (fr) 1983-09-12
AU9030682A (en) 1983-05-19
ES523083A0 (es) 1985-02-16
DK499582A (da) 1983-05-11
DK161325C (da) 1991-12-02
PH22764A (en) 1988-12-12

Similar Documents

Publication Publication Date Title
NO158100C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater.
NO157620C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo -diazepiner.
NO157781C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye imidazo(1,2-a)pyridiner.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO159724C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazo(1,2-a)-pyraziner.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO156373C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO154905C (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO157819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO161319C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo-(1,5-a)pyridin-derivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
NO159276C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo(1,5-a)pyridiner.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO160442C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolo (1,5-a)pyridinderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.